Contribution and Value of Biomarkers in Acute Aortic Syndromes

---

Atıf İçin Kopyala

Yildiz M., Oksen D., Behnes M., Akin I.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, cilt.18, sa.6, ss.495-498, 2017 (SCI-Expanded)

• Yayın Türü: Makale / Derleme
• Cilt numarası: 18 Sayı: 6
• Basım Tarihi: 2017
• Doi Numarası: 10.2174/1389201018666170615081727
• Dergi Adı: CURRENT PHARMACEUTICAL BIOTECHNOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.495-498
• İstanbul Üniversitesi Adresli: Evet

Özet

Background: Acute aortic syndromes, being mostly underdiagnosed due to unspecific symptoms, are associated with high morbidity and mortality. Diagnosis carried out by transesophageal echocardiography, computed tomography and magnetic resonance imaging. However, there are lots of biochemical assays being investigated, but none of them used reliably to identify acute aortic syndromes. Biomarkers could accelerate the diagnostic time with cost effective way and could get place in definitive diagnostic algorithm of acute aortic syndrome. This review aims to identify contribution and value of biomarkers in acute aortic syndromes.